Delaware District Court Dismisses Genentech v. Amgen

U.S. Biosimilar Litigation News

As we previously reported, yesterday Judge Sleet, United States District Court for the District of Delaware, heard arguments on Amgen’s motion to dismiss in Genentech v. Sandoz.  The court orally granted Amgen’s motion under the Federal Circuit’s holding in Amgen v. Sandoz.  The court dismissed Genentech’s complaint in its entirety without prejudice and with leave to amend within 45 days.

Stay tuned to Big Molecule Watch for more analysis.

Download PDF

Comments are closed.